Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Hemagen Diagnostics's Average Total Inventories for the quarter that ended in Sep. 2012 was $1.37 Mil. Hemagen Diagnostics's Revenue for the
three
months ended in Sep. 2012 was $0.88 Mil.
Hemagen Diagnostics's Inventory-to-Revenue for the quarter that ended in Sep. 2012 was 1.56.
Hemagen Diagnostics's Inventory-to-Revenue for the quarter that ended in Sep. 2012
increased
from Jun. 2012 (1.44) to Jun. 2012 (1.56)
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Hemagen Diagnostics's Days Inventory for the
three
months ended in Sep. 2012 was 262.78.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Hemagen Diagnostics's Inventory Turnover for the quarter that ended in Sep. 2012 was 0.35.
Hemagen Diagnostics Inventory-to-Revenue Historical Data
The historical data trend for Hemagen Diagnostics's Inventory-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Hemagen Diagnostics's Inventory-to-Revenue
For the Biotechnology subindustry, Hemagen Diagnostics's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hemagen Diagnostics's Inventory-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Hemagen Diagnostics's Inventory-to-Revenue distribution charts can be found below:
* The bar in red indicates where Hemagen Diagnostics's Inventory-to-Revenue falls into.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Hemagen Diagnostics's Inventory-to-Revenue for the fiscal year that ended in Sep. 2012 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:
1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.
More Related Terms:
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Hemagen Diagnostics's Days Inventory for the
three
months ended in Sep. 2012 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hemagen Diagnostics Inventory-to-Revenue Related Terms
Thank you for viewing the detailed overview of Hemagen Diagnostics's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Hemagen Diagnostics (Hemagen Diagnostics) Business Description
Hemagen Diagnostics Inc is a biotechnology company. It develops, manufactures and markets Food and Drug Administration cleared proprietary medical diagnostic test kits and components. The company's Virgo line of Immunoassays are used to aid in the diagnosis of autoimmune and infectious diseases and acute-phase proteins. The assays utilize multiple technologies including ELISA, immunofluorescence (IFA) and hemagglutination (HA). Its products include ANA Screen ELISA 96 Test System, Rubella IgG ELISA 96 Test System, AMA IFA 48 Test System and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HMGN has been successfully added to your 